A revolutionary one-shot therapy for juvenile and adult-onset glaucoma affected by MYOC mutations, offering a permanent cure for this previously untreatable disease.

An innovative small molecules therapy that significantly lowers intraocular pressure in glaucoma patients, offering neuroprotection and addressing trabecular meshwork fibrosis.

This technology introduces a novel class of synthetic genetic polymers, capable of enhancing protein target binding and mimicking antibodies, for therapeutic and diagnostic applications.

This technology encompasses a suite of patents for developing gyroscopes that offer both broad bandwidth and high sensitivity, suitable for a variety of challenging environments.

An innovative air-based force sensor designed to enhance the safety and precision of surgical instrument insertions.

Researchers at UCI and Harvard have engineered a new platform for diversifying antibody genes in yeast, eliminating a crucial bottleneck in making effective antibodies. This technology enables the rapid continuous directed evolution of affinity reagents for applications ranging from structural and cellular biology to diagnostics and immunotherapy.

BMSO represents a groundbreaking advancement in crosslinking mass spectrometry (XL-MS), enabling comprehensive mapping of protein-protein interactions.

A revolutionary vaccine platform enabling the co-delivery of multiple toll-like receptor agonists and an antigen for potent immune responses.